LIFECORE BIOMEDICAL, INC. Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments
LIFECORE BIOMEDICAL, INC. (LFCR) had Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments of $3.63 million as of 2019-05-26, per its 10-K filed 2020-08-14.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments · last filed 2020-08-14
- 2019-05-26: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $3.63M.
- 2018-05-27: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $3.73M.
- 2017-05-28: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $3.80M.
- 2016-05-29: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $3.86M.
| Period end | Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments |
|---|---|
| 2019-05-26 | $3.63M 10-K · filed 2020-08-14 |
| 2018-05-27 | $3.73M 10-K · filed 2018-08-09 |
| 2017-05-28 | $3.80M 10-K/A · filed 2018-03-15 |
| 2016-05-29 | $3.86M 10-K · filed 2016-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |